BiotechTube

Prograf-XL + Prograf + MMF

Phase 3Completed
3 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Liver Transplantation

Conditions

Liver Transplantation, Transplantation Immunology, Host vs Graft Reaction

Trial Timeline

Dec 1, 2007 → Sep 1, 2009

NCT ID
NCT00720408

About Prograf-XL + Prograf + MMF

Prograf-XL + Prograf + MMF is a phase 3 stage product being developed by Astellas Pharma for Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00720408. Target conditions include Liver Transplantation, Transplantation Immunology, Host vs Graft Reaction.

What happened to similar drugs?

20 of 20 similar drugs in Liver Transplantation were approved

Approved (20) Terminated (3) Active (0)
✅Advagraf + Prograf + PrografAstellas PharmaApproved
✅Prograf + AdvagrafAstellas PharmaApproved
✅ADVAGRAF®Astellas PharmaApproved
✅Tacrolimus granules + Tacrolimus granulesAstellas PharmaApproved
✅Advagraf + PrografAstellas PharmaApproved
✅ADVAGRAF®Astellas PharmaApproved
✅tacrolimus + mycophenolate mofetil + PrednisoneAstellas PharmaApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00717678Phase 3Completed
NCT00720408Phase 3Completed

Competing Products

20 competing products in Liver Transplantation

See all competitors
ProductCompanyStageHype Score
LanifibranorInventivaPhase 2
29
GODEX + PlaceboCelltrionPhase 3
47
peginterferon alfa-2a 180μg + peginterferon alfa-2a 90μg + ribavirinChugai PharmaceuticalPhase 3
40
exatecan mesylateDaiichi SankyoPhase 2
35
TacrolimusAstellas PharmaPre-clinical
26
ATG (Fresenius Biotech)Astellas PharmaPhase 2
27
Advagraf + Prograf + PrografAstellas PharmaApproved
43
Prograf + AdvagrafAstellas PharmaApproved
43
ADVAGRAF®Astellas PharmaApproved
43
Prograf + MR4Astellas PharmaPhase 3
40
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
35
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
35
tacrolimusAstellas PharmaPhase 3
40
micafungin + fluconazole + liposomal amphotericin B + caspofunginAstellas PharmaPhase 3
40
Tacrolimus granules + Tacrolimus granulesAstellas PharmaApproved
43
FK506E (modified release tacrolimus) + Prograf (tacrolimus)Astellas PharmaPhase 3
40
FK778Astellas PharmaPhase 2
35
Tacrolimus modified-release + PrografAstellas PharmaPhase 3
40
Advagraf + PrografAstellas PharmaApproved
39
Prograf + FK506MR capsuleAstellas PharmaPhase 3
40